(b) Integrin α7 might regulate multiple pathways (including the corresponding FAK/MAPK/ERK pathway) to increase stemness of cancer cells, subsequently enhancing the abilities to self‐renew, differentiate and chemoresistance, which caused poor survival in ccRCC patients. Here, PTK2 is linked to cancer.